Literature DB >> 23983924

Physical complications in early clozapine treatment: a case report and implications for safe monitoring.

Sachin S Patel1, Matthew P G Allin.   

Abstract

Treatment with the antipsychotic clozapine is often complicated by its wide-ranging and sometimes serious adverse effect profile. A link between clozapine therapy and diabetes is well established, although the onset and severity of glucose metabolism abnormalities is variable. Recent literature also suggests there may be an association between clozapine therapy and pneumonia. We review the relevant background literature and present a case of a patient with pre-existing type 2 diabetes mellitus and chronic obstructive pulmonary disease who presented with a diabetic emergency after a relatively short period of treatment with clozapine. He went on to develop pneumonia from which he died. We discuss the implications this case, and others alike, have for early routine physical health monitoring of this patient group.

Entities:  

Keywords:  clozapine; diabetes; monitoring; pneumonia; schizoaffective disorder; schizophrenia

Year:  2011        PMID: 23983924      PMCID: PMC3736897          DOI: 10.1177/2045125311398284

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  15 in total

Review 1.  Consensus development conference on antipsychotic drugs and obesity and diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

Review 2.  Esophageal dysfunction on psychotropic medication. A case report and literature review.

Authors:  Alessia S Maddalena; Mark Fox; Marc Hofmann; Christoph Hock
Journal:  Pharmacopsychiatry       Date:  2004-05       Impact factor: 5.788

3.  Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice.

Authors:  Elizabeth Tovey; Hagen Rampes; Callum Livingstone
Journal:  J Psychopharmacol       Date:  2005-03       Impact factor: 4.153

4.  Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.

Authors:  David C Henderson; Dana D Nguyen; Paul M Copeland; Doug L Hayden; Christina P Borba; Pearl M Louie; Oliver Freudenreich; A Eden Evins; Corrine Cather; Donald C Goff
Journal:  J Clin Psychiatry       Date:  2005-09       Impact factor: 4.384

5.  Clozapine-associated diabetes.

Authors:  E Koller; B Schneider; K Bennett; G Dubitsky
Journal:  Am J Med       Date:  2001-12-15       Impact factor: 4.965

Review 6.  Diabetes and schizophrenia 2005: are we any closer to understanding the link?

Authors:  Richard I G Holt; Chris Bushe; Leslie Citrome
Journal:  J Psychopharmacol       Date:  2005-11       Impact factor: 4.153

7.  Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection.

Authors:  David M Taylor; Petrina Douglas-Hall; Banke Olofinjana; Eromona Whiskey; Arwel Thomas
Journal:  Br J Psychiatry       Date:  2009-02       Impact factor: 9.319

Review 8.  Diabetic ketoacidosis among patients receiving clozapine: a case series and review of socio-demographic risk factors.

Authors:  Nikhil D Nihalani; Xin Tu; J Steven Lamberti; David Olson; Telva Olivares; G Oana Costea; Wan Tang
Journal:  Ann Clin Psychiatry       Date:  2007 Apr-Jun       Impact factor: 1.567

9.  Antipsychotic drug use and risk of pneumonia in elderly people.

Authors:  Wilma Knol; Rob J van Marum; Paul A F Jansen; Patrick C Souverein; Alfred F A M Schobben; Antoine C G Egberts
Journal:  J Am Geriatr Soc       Date:  2008-02-07       Impact factor: 5.562

10.  A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance.

Authors:  Oliver D Howes; Ajay Bhatnagar; Fiona P Gaughran; Stephanie A Amiel; Robin M Murray; Lyn S Pilowsky
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

View more
  3 in total

1.  Clozapine Associated with Autoimmune Reaction, Fever and Low Level Cardiotoxicity - A Case Report.

Authors:  Charilaos Gerasimou; Georgia Phaedra Vitali; George D Vavougios; Charalabos Papageorgiou; Athanasios Douzenis; Styliani I Kokoris; Ioannis Liappas; Emmanouil Rizos
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

Review 2.  Neuroleptic malignant syndrome: an easily overlooked neurologic emergency.

Authors:  Ramadhan Oruch; Ian F Pryme; Bernt A Engelsen; Anders Lund
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-16       Impact factor: 2.570

Review 3.  Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses.

Authors:  Janet Sultana; Marco Calabró; Ricard Garcia-Serna; Carmen Ferrajolo; Concetta Crisafulli; Jordi Mestres; Gianluca Trifirò'
Journal:  PLoS One       Date:  2017-10-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.